OpenVSafe by OpenVAERS
Search V-safe

2SQ-18052-17761

3 vaccinations 0 coded responses 7 check-ins 0 free-text entries 0 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
156 / PA
Registered
2022-04-06
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-24
    Dose 1 — Pfizer-BioNTech
  2. 2021-02-14
    Dose 2 — Pfizer-BioNTech
  3. 2022-04-06
    Registered in v-safe
  4. 2022-04-06
    Dose 3 — Pfizer-BioNTech
  5. 2022-04-06
    Health check-in — day 0, dose 3
    Feeling: Fair · Muscle or body aches
    Adult check-in
  6. 2022-04-07
    Health check-in — days 1–6 daily, dose 3
    Feeling: Poor · Site: Pain · Chills, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school
    Adult check-in
  7. 2022-04-09
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · Headache, Fatigue or tiredness, Nausea
    Adult check-in
  8. 2022-04-10
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  9. 2022-04-11
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  10. 2022-04-13
    Health check-in — day 7, dose 3
    Feeling: Good · Headache, Fatigue or tiredness
    Adult check-in
  11. 2022-04-20
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-01-24Pfizer-BioNTech No
22021-02-14Pfizer-BioNTech No
32022-04-06Pfizer-BioNTech No

Free text

None.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

No MedDRA codes.